科前生物2021三季报显示，公司主营收入7.76亿元，同比上升28.37%；归母净利润3.86亿元，同比上升20.69%；扣非净利润3.76亿元，同比上升20.04%；其中2021年第三季度，公司单季度主营收入2.31亿元，同比下降7.42%；单季度归母净利润9976.47万元，同比下降27.1%；单季度扣非净利润9791.47万元，同比下降26.21%；负债率18.68%，投资收益376.65万元，财务费用-4530.47万元，毛利率79.15%。
本期共有8个新进十大流通股东，黄青伟 持股138.5026万股，占流通股比例1.15%，牧原实业集团有限公司 持股1680.0万股，占流通股比例13.97%，汤细彪 持股234.0081万股，占流通股比例1.95%，魏燕鸣 持股207.4493万股，占流通股比例1.72%，李江华 持股211.7112万股，占流通股比例1.76%，陈关平 持股180.0077万股，占流通股比例1.5%，张锦军 持股234.0081万股，占流通股比例1.95%，徐高原 持股352.1995万股，占流通股比例2.93%；共有1股东增持，中国工商银行-南方宝元债券型基金增持35.6789万股，该股东持股占流通股比例1.38%；共有1股东减持，中国银行股份有限公司-大成优选混合型证券投资基金(LOF)减持150.0万股，该股东持股占流通股比例1.25%；
财报数据概要请见下图:
本文由证券之星数据中心根据公开数据汇总整理，不构成投资意见或建议，如有文中存在问题，请联系我们。
According to the third quarterly report of pre-science biology 2021, the company's main income was 776 million yuan, up 28.37% from the same period last year; the net profit was 386 million yuan, up 20.69% from the same period last year; and deducting 376 million yuan from non-net profit, up 20.04% from the same period last year. In the third quarter of 2021, the company's main income in a single quarter was 231 million yuan, down 7.42% from the same period last year; the net profit in a single quarter was 99.7647 million yuan, down 27.1% from the same period last year The non-net profit in a single quarter was 97.9147 million yuan, down 26.21% from the same period last year; the debt ratio was 18.68%, the investment income was 3.7665 million yuan, the financial expenses were-45.3047 million yuan, and the gross profit margin was 79.15%.
There are eight new top ten tradable shareholders in this period. Huang Qingwei holds 1.385026 million shares, accounting for 1.15% of tradable shares, Muyuan Industrial Group Co., Ltd. holds 16.8 million shares, accounting for 13.97% of tradable shares, Tang Xibiao holds 2.340081 million shares, accounting for 1.95% of tradable shares. Wei Yanming holds 2.074493 million shares, accounting for 1.72% of tradable shares, and Li Jianghua holds 2.1171.12 million shares. It accounts for 1.76% of tradable shares, 1.800077 million shares held by Chen Guanping, accounting for 1.5% of tradable shares, 2.340081 million shares held by Zhang Jinjun, accounting for 1.95% of tradable shares, and 3.521995 million shares held by Xu Plateau, accounting for 2.93% of tradable shares. A total of 1 shareholder increased their holdings, China Industrial and Commercial Bank of China-Southern Baoyuan Bond Fund increased its holdings by 356789 shares, accounting for 1.38% of tradable shares; a total of 1 shareholder reduced their holdings, Bank of China Ltd. Co., Ltd.-Dacheng preferred mixed Securities Investment Fund (LOF) reduced its holdings by 1.5 million shares, accounting for 1.25% of tradable shares.
For a summary of the financial report data, please see the following figure:
This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If there are any questions in the article, please contact us.
